|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1966)) |
IUPAC Name ![]() |
| adamantan-1-amine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1816 | amantadine |
Synonyms ![]() |
| Symadine® |
Database Links ![]() |
|
| CAS Registry No. | 768-94-5 (source: Scifinder) |
| ChEBI | CHEBI:2618 |
| ChEMBL Ligand | CHEMBL660 |
| DrugBank Ligand | DB00915 |
| PubChem CID | 2130 |
| Search Google for chemical match using the InChIKey | DKNWSYNQZKUICI-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | DKNWSYNQZKUICI |
| Search PubMed clinical trials | amantadine |
| Search PubMed titles | amantadine |
| Search PubMed titles/abstracts | amantadine |
| Wikipedia | Amantidine |
| Comments |
| Chemically amantidine has an adamantane backbone with an amino group substituted at one of the four methyne positions. Clinically it has antiviral (blocking the viral M2 proton channel) and antiparkinsonian actions. |